Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Xenon Pharmaceuticals Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 276 shares of XENE stock, worth $10,543. This represents 0.0% of its overall portfolio holdings.
Number of Shares
276
Previous 276
-0.0%
Holding current value
$10,543
Previous $10,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding XENE
# of Institutions
218Shares Held
66.6MCall Options Held
109KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$216 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$173 Million1.73% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$111 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$110 Million0.06% of portfolio
-
Commodore Capital LP New York, NY2.74MShares$105 Million10.76% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.38B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...